The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia
Catheter-related bloodstream infection (C-RBSI) is one of the most frequent nosocomial infections. It is associated with high rates of morbidity and mortality. Candida spp. is the third most common cause of C-RBSI after coagulase-negative staphylococci and Staphylococcus aureus and is responsible fo...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2014-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_bc5f19a5d51b44d0a31df1a43012bac3 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Emilio Bouza |e author |
| 700 | 1 | 0 | |a Jesús Guinea |e author |
| 700 | 1 | 0 | |a María Guembe |e author |
| 245 | 0 | 0 | |a The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia |
| 260 | |b MDPI AG, |c 2014-12-01T00:00:00Z. | ||
| 500 | |a 2079-6382 | ||
| 500 | |a 10.3390/antibiotics4010001 | ||
| 520 | |a Catheter-related bloodstream infection (C-RBSI) is one of the most frequent nosocomial infections. It is associated with high rates of morbidity and mortality. Candida spp. is the third most common cause of C-RBSI after coagulase-negative staphylococci and Staphylococcus aureus and is responsible for approximately 8% of episodes. The main cause of catheter-related candidemia is the ability of some Candida strains-mainly C. albicans and C. parapsilosis-to produce biofilms. Many in vitro and in vivo models have been designed to assess the activity of antifungal drugs against Candida biofilms. Echinocandins have proven to be the most active antifungal drugs. Potential options in situations where the catheter cannot be removed include the combination of systemic and lock antifungal therapy. However, well-designed and -executed clinical trials must be performed before firm recommendations can be issued. | ||
| 546 | |a EN | ||
| 690 | |a biofilm | ||
| 690 | |a Candida | ||
| 690 | |a antifungals | ||
| 690 | |a catheter-related candidemia | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Antibiotics, Vol 4, Iss 1, Pp 1-17 (2014) | |
| 787 | 0 | |n http://www.mdpi.com/2079-6382/4/1/1 | |
| 787 | 0 | |n https://doaj.org/toc/2079-6382 | |
| 856 | 4 | 1 | |u https://doaj.org/article/bc5f19a5d51b44d0a31df1a43012bac3 |z Connect to this object online. |